Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids
NCT02577055
Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial
NCT03021720
Role of Uterine Artery Embolization in Adenomyosis
NCT05597644
Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives
NCT01852734
Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
NCT00821275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Uterine Artery Embolization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmation of fibroids by endovaginal and transabdominal ultrasound
Exclusion Criteria
* Desire for fertility
* Carcinoma of pelvic organs
* Previous pelvic irradiation
* Bleeding diathesis and vasculitis
* History of allergiy to contrst medium
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manitoba
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard S Boroditsky, MD
Role: PRINCIPAL_INVESTIGATOR
University of Manitoba
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Sciences Centre
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2000 115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.